表紙
市場調查報告書
商品編碼
974798

植物為基礎的生技藥品市場:各產品類型,各來源類型,各適應症,各地區:規模,佔有率,預測,及機會分析(2020年∼2027年)

Plant-based Biologics Market, by Product Type, by Source Type, by Disease Indication, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

出版日期: | 出版商: Coherent Market Insights | 英文 204 Pages | 商品交期: 2-3個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

植物為基礎的生技藥品,是使用植物分子工廠(PMF)製造的生技藥品。也稱為植物製生技藥品(PMB)。植物為基礎的生技藥品的用途和優點,超越疫苗和治療性蛋白質的傳統境界而擴大。

各種慢性疾病的生技藥品的需求增加與對生物製品生產的研究開發的投資擴大,預計對植物為基礎的生技藥品市場成長有大幅貢獻。

本報告提供植物為基礎的生技藥品市場相關調查,市場概要,以及各產品類型,各來源類型,各適應症,各地區的趨勢,及加入此市場的主要企業簡介等資訊。

目錄

第1章 調查目的、前提條件

第2章 市場概要

  • 報告的說明
    • 市場定義和範圍
  • 摘要整理
    • 市場明細:各產品類型
    • 市場明細:各來源類型
    • 市場明細:各適應症
    • 市場明細:各地區
  • Coherent Opportunity Map(COM)

第3章 市場動態,法規,及趨勢分析

  • 促進因素
  • 阻礙因素
  • 市場機會
  • 影響分析
  • 市場趨勢
  • 開發平台分析
  • 法規方案
  • 植物為基礎的生物學的醫藥品製造的主要技術平台
  • PEST分析
  • 政府的輔助

第4章 植物為基礎的生技藥品市場-冠狀病毒(Covid-19)大流行的影響

  • 中-COVID19市場的狀況
  • 對國家的整體影響
  • 新的開發

第5章 全球植物為基礎的生技藥品市場:各產品類型,2016年∼2027年,(百萬美元)

  • 簡介
  • 單株抗體
  • Alpha干擾素
  • Glucocerebrosidase
  • 疫苗
  • 其他

第6章 全球植物為基礎的生技藥品市場:各來源類型,2016年∼2027年,(百萬美元)

  • 簡介
  • 胡蘿蔔
  • 香煙的葉
  • 稻種子
  • 紫花苜蓿
  • 其他

第7章 全球植物為基礎的生技藥品市場:各適應症,2016年∼2027年,(百萬美元)

  • 簡介
  • 高雪氏症
  • 蛀牙
  • 肝炎
  • 淋巴瘤
  • 其他

第8章 全球植物為基礎的生技藥品市場:各地區,2016年∼2027年,(百萬美元)

  • 簡介
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東
  • 非洲

第9章 競爭情形

  • 企業簡介
    • Leaf Expression Systems
    • Zea Biosciences
    • Planet Biotechnology Inc.
    • InVitria
    • PlantForm Corporation
    • IBIO, Inc.
    • Mapp Biopharmaceutical, Inc.
    • Pfizer Inc.
    • Ventria Bioscience Inc.
    • Medicago Inc.
    • Eleva GmbH
    • Kentucky Bioprocessing, LLC
    • Solarvest Bioenergy Inc.
    • : Byondis BV

第10章 Section

目錄

Title:
Plant-based Biologics Market, by Product Type (Monoclonal Antibodies, Alpha Interferon, Glucocerebrosidase, Vaccines, and Others), by Source Type (Carrot, Tobacco Leaves, Rice Seeds, Alfalfa, and Others), by Disease Indication (Gaucher Disease, Tooth Decay, Hepatitis, Lymphoma, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027.

Plant-based biologics are biologic drugs that are manufactured by using plant molecular farming. They are also known as plant-made biologics (PMB). The applications and advantages of plant-based biologics have stretched beyond the traditional boundaries of vaccines and therapeutic proteins. For instance, bacterial colicins derived from plants in 2015 were recently proven effective as food additives for controlling pathogenic bacteria in food products. These colicins are highly effective (even when used in lower concentrations) to fight against all the pathogenic Escherichia coli strains that cause food poisoning. Moreover, it costs around US$ 1.00 for manufacturing one gram of purified colicins, which is commercially viable.

Market Dynamics

The increasing demand for biologics for various chronic diseases and rising investments in R&D for the production of biologics are expected to contribute significantly to the growth of plant-based biologics market. For instance, according to the Biotechnology Innovation Organization (BIO) 2015, over 250 biologic therapies and vaccines have changed the lives of hundreds of millions of patients. Moreover, according to the same source, over 900 biologics are currently (2018) under the stage of development for over 100 diseases in the U.S. Furthermore, according to the Pharmaceutical Research and Manufacturers of America (PhRMA), 2016, member companies invested around US$ 58.8 billion in research and development in 2015, of which, majority of the investments was made by all the biopharmaceutical companies in the U.S. for the treatment of rare diseases.

Many biopharmaceutical companies are focused on developing plant-made pharmaceuticals using various plants such as tobacco, duckweed, moss, alfalfa, and other plants, which is expected to propel growth of the plant-based biologics market. For instance, in September 2015, LeafBio, Inc., the commercial partner of Mapp Biopharmaceutical, Inc. (Mapp), was granted fast track designation by the U.S. Food and Drug Administration (FDA) for their plant-made drug ZMapp for the treatment of Ebola virus disease.

However, stringent regulatory guidelines for the production of plant-based biologics is one of the major factors restraining growth of the plant-based biologics market. Moreover, concern regarding contamination and environmental risks is another factor restraining growth of the market.

Key features of the study:

  • This report provides in-depth analysis of the global plant-based biologics market, market size (US$ Mn), and compound annual growth rate (CAGR (%)) for the forecast period: 2020-2027, considering 2019 as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by leading players
  • It profiles key players in the global plant-based biologics market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
  • Key players covered as a part of this study include Leaf Expression Systems, Zea Biosciences, Planet Biotechnology Inc., InVitria, PlantForm Corporation, IBIO, Inc., Mapp Biopharmaceutical, Inc., Pfizer Inc., Ventria Bioscience Inc., Medicago Inc., Eleva GmbH, Kentucky Bioprocessing, LLC, Solarvest Bioenergy Inc., and Byondis B.V.
  • Insights from this report would allow marketers and management authorities of companies to make informed decisions with respect to future product launches, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
  • The global plant-based biologics market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for plant-based biologics market, research and consulting firms, new entrants, and financial analysts.

Detailed Segmentation:

  • Global Plant-based Biologics Market, By Product Type:
    • Monoclonal Antibodies
    • Alpha Interferon
    • Glucocerebrosidase
    • Vaccines
    • Others
  • Global Plant-based Biologics Market, By Source Type:
    • Carrot
    • Tobacco Leaves
    • Rice Seeds
    • Alfalfa
    • Others
  • Global Plant-based Biologics Market, By Disease Indication:
    • Gaucher Disease
    • Tooth Decay
    • Hepatitis
    • Lymphoma
    • Others
  • Global Plant-based Biologics Market, By Region:
    • North America
      • By Country:
    • U.S.
    • Canada
      • By Product Type:
    • Monoclonal Antibodies
    • Alpha Interferon
    • Glucocerebrosidase
    • Vaccines
    • Others
      • By Source Type:
    • Carrot
    • Tobacco Leaves
    • Rice Seeds
    • Alfalfa
    • Others
      • By Disease Indication:
    • Gaucher Disease
    • Tooth Decay
    • Hepatitis
    • Lymphoma
    • Others
    • Europe
      • By Country:
    • U.K.
    • Germany
    • Italy
    • Spain
    • France
    • Russia
    • Rest of Europe
      • By Product Type:
    • Monoclonal Antibodies
    • Alpha Interferon
    • Glucocerebrosidase
    • Vaccines
    • Others
      • By Source Type:
    • Carrot
    • Tobacco Leaves
    • Rice Seeds
    • Alfalfa
    • Others
      • By Disease Indication:
    • Gaucher Disease
    • Tooth Decay
    • Hepatitis
    • Lymphoma
    • Others
    • Asia Pacific
      • By Country:
    • Australia
    • India
    • China
    • Japan
    • ASEAN
    • South Korea
    • Rest of Asia Pacific
      • By Product Type:
    • Monoclonal Antibodies
    • Alpha Interferon
    • Glucocerebrosidase
    • Vaccines
    • Others
      • By Source Type:
    • Carrot
    • Tobacco Leaves
    • Rice Seeds
    • Alfalfa
    • Others
      • By Disease Indication:
    • Gaucher Disease
    • Tooth Decay
    • Hepatitis
    • Lymphoma
    • Others
    • Latin America
      • By Country:
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
      • By Product Type:
    • Monoclonal Antibodies
    • Alpha Interferon
    • Glucocerebrosidase
    • Vaccines
    • Others
      • By Source Type:
    • Carrot
    • Tobacco Leaves
    • Rice Seeds
    • Alfalfa
    • Others
      • By Disease Indication:
    • Gaucher Disease
    • Tooth Decay
    • Hepatitis
    • Lymphoma
    • Others
    • Middle East
      • By Country:
    • GCC
    • Israel
    • Rest of Middle East
      • By Product Type:
    • Monoclonal Antibodies
    • Alpha Interferon
    • Glucocerebrosidase
    • Vaccines
    • Others
      • By Source Type:
    • Carrot
    • Tobacco Leaves
    • Rice Seeds
    • Alfalfa
    • Others
      • By Disease Indication:
    • Gaucher Disease
    • Tooth Decay
    • Hepatitis
    • Lymphoma
    • Others
    • Africa
      • By Country/Region:
    • South Africa
    • Central Africa
    • North Africa
      • By Product Type:
    • Monoclonal Antibodies
    • Alpha Interferon
    • Glucocerebrosidase
    • Vaccines
    • Others
      • By Source Type:
    • Carrot
    • Tobacco Leaves
    • Rice Seeds
    • Alfalfa
    • Others
      • By Disease Indication:
    • Gaucher Disease
    • Tooth Decay
    • Hepatitis
    • Lymphoma
    • Others
  • Company Profiles
    • Leaf Expression Systems*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Strategies
    • Zea Biosciences
    • Planet Biotechnology Inc.
    • InVitria
    • PlantForm Corporation
    • IBIO, Inc.
    • Mapp Biopharmaceutical, Inc.
    • Pfizer Inc.
    • Ventria Bioscience Inc.
    • Medicago Inc.
    • Eleva GmbH
    • Kentucky Bioprocessing, LLC
    • Solarvest Bioenergy Inc.
    • Byondis B.V.

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Overview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Product Type
    • Market Snippet, By Source Type
    • Market Snippet, By Disease Indication
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Drivers
  • Restraints
  • Market Opportunities
  • Impact Analysis
  • Market Trends
  • Pipeline Analysis
  • Regulatory Scenario
  • Major Technology Platforms For Plant-based Biologic Drug Production
  • PEST Analysis
  • Government Support

4. Plant-based Biologics Market - Impact of Coronavirus (Covid-19) Pandemic

  • During-COVID 19 Market Situation
  • Overall Impact On Countries
  • New Developments

5. Global Plant-based Biologics Market, By Product Type, 2016 - 2027, (US$ Million)

  • Introduction
    • Market Share Analysis, 2020 and 2027 (%)
    • Y-o-Y Growth Analysis, 2017 - 2027
    • Segment Trends
  • Monoclonal Antibodies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Alpha Interferon
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Glucocerebrosidase
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Vaccines
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)

6. Global Plant-based Biologics Market, By Source Type, 2016 - 2027, (US$ Million)

  • Introduction
    • Market Share Analysis, 2020 and 2027 (%)
    • Y-o-Y Growth Analysis, 2017 - 2027
    • Segment Trends
  • Carrot
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Tobacco Leaves
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Rice Seeds
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Alfalfa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)

7. Global Plant-based Biologics Market, By Disease Indication, 2016 - 2027, (US$ Million)

  • Introduction
    • Market Share Analysis, 2020 and 2027 (%)
    • Y-o-Y Growth Analysis, 2017 - 2027
    • Segment Trends
  • Gaucher Disease
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Tooth Decay
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Hepatitis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Lymphoma
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)

8. Global Plant-based Biologics Market, By Region, 2016 - 2027, (US$ Million)

  • Introduction
    • Market Share Analysis, By Region, 2020 and 2027 (%)
    • Y-o-Y Growth Analysis, By Region, 2017 - 2027
    • Regional Trends
  • North America
    • Market Size and Forecast, By Product Type, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By Source Type, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By Disease Indication, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Million)
    • U.S.
    • Canada
  • Europe
    • Market Size and Forecast, By Product Type, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By Source Type, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By Disease Indication, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Million)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Product Type, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By Source Type, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By Disease Indication, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Million)
    • China
    • Japan
    • India
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Market Size and Forecast, By Product Type, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By Source Type, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By Disease Indication, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Million)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Middle East
    • Market Size and Forecast, By Product Type, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By Source Type, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By Disease Indication, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Million)
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • Market Size and Forecast, By Product Type, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By Source Type, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By Disease Indication, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By Country/Region, 2016 - 2027, (US$ Million)
    • North Africa
    • Central Africa
    • South Africa

9. Competitive Landscape

  • Company Profiles
    • Leaf Expression Systems
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Zea Biosciences
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Planet Biotechnology Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • InVitria
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • PlantForm Corporation
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • IBIO, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Mapp Biopharmaceutical, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Pfizer Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Ventria Bioscience Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Medicago Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Eleva GmbH
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Kentucky Bioprocessing, LLC
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Solarvest Bioenergy Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Byondis B.V
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies

10. Section

  • References
  • Research Methodology
  • About us and Sales Contact